Looking towards the future, what advancements do you anticipate in the treatment landscape for PNH and other complement-driven rare diseases, particularly in relation to investigational therapeutics targeting the alternative pathway?

Related Content

senior scientist | Image credit: Ohio State University

April 28th 2025

Proving the Concept: A Sampler of Early-Stage Science at AACR 2025

Mary Caffrey

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ground.

December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

April 24th 2025

Science at AACR Aims to Overcome Cancer Care Barriers

Mary Caffrey Brooke McCormick

A program cochair said the agenda was designed to get attendees "out of their comfort zone." The Amercian Association for Cancer Research annual meeting runs April 25-30, with the key presentations coming Sunday through Tuesday.

December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.

April 23rd 2025

Contributor: For Complex Cases, Continuity in Acute Care Is Necessary

Jubril Oyeyemi, MD

For patients with complex needs and social challenges like unstable housing, the hospital has become their de facto medical home—yet each visit is a fragmented restart, without continuity, context, or a clear path forward.

Woman measuring man's waist with tape measure | Image Credit: fotoduets - stock.adobe.com

April 23rd 2025

Higher Weight-Adjusted Waist Index Tied to Greater Mortality Risk in Patients With Osteoarthritis

Brooke McCormick

Researchers consider the weight-adjusted waist index a more precise predictor of mortality risk in patients with osteoarthritis than traditional obesity measures, like body mass index.

Related Content

April 28th 2025

Proving the Concept: A Sampler of Early-Stage Science at AACR 2025

Mary Caffrey

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ground.

December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

April 24th 2025

Science at AACR Aims to Overcome Cancer Care Barriers

Mary Caffrey Brooke McCormick

December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.

April 23rd 2025

Contributor: For Complex Cases, Continuity in Acute Care Is Necessary

Jubril Oyeyemi, MD

April 23rd 2025

Higher Weight-Adjusted Waist Index Tied to Greater Mortality Risk in Patients With Osteoarthritis

Brooke McCormick

Researchers consider the weight-adjusted waist index a more precise predictor of mortality risk in patients with osteoarthritis than traditional obesity measures, like body mass index.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions